Cancer Research Progress
Ned shares his insights on the remarkable pace of progress in cancer research, emphasizing its exceptional nature compared to other diseases. He highlights the challenges in communicating this progress due to its heterogeneous nature, while noting that during his time at the FDA, a significant portion of new drug and device approvals were cancer-related. His unique experiences as a researcher, entrepreneur, and regulator provide him with a multifaceted perspective on the field.In this clip
From this podcast
Freakonomics Radio
How to Fix the Incentives in Cancer Research | Freakonomics Radio | Episode 449
Related Questions